PDCD1 and glioblastoma: In addition, metformin significantly increased tumor-infiltrating CD4+ T cells in mouse glioblastoma models, while reducing regulatory T (Treg) cells, with or without the combination of anti-programmed cell death 1 (PD-1) antibodies, according to a recent study (73).